Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results、 Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
This report contains market size and forecasts of Infectious Disease POC Diagnostic in global, including the following market information:
Global Infectious Disease POC Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Disease POC Diagnostic Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Disease POC Diagnostic companies in 2021 (%)
The global Infectious Disease POC Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lateral Flow Immunoassay Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease POC Diagnostic include F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, Quest Diagnostics, BD, bioMérieux, Cardinal Health, Cepheid and Trinity Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease POC Diagnostic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease POC Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease POC Diagnostic Market Segment Percentages, by Type, 2021 (%)
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others
Global Infectious Disease POC Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease POC Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospital Bedside
Urgent Care and Retail Clinics
Home and Self-Testing
Others
Global Infectious Disease POC Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Disease POC Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease POC Diagnostic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Disease POC Diagnostic revenues share in global market, 2021 (%)
Key companies Infectious Disease POC Diagnostic sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Disease POC Diagnostic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
bioMérieux
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories